News for Biophytis SA (BPTS)

Biophytis SA (BPTSY) Tuesday unveiled its strategic outlook for the year and said that 2025 will be decisive for the company, with several major initiatives to accelerate the clinical development of BIO101 (20-Hydroxyecdysone) and its commercialization.

H.C. Wainwright optimistic on Biophytis stock as Phase 2 trial approved

NEW YORK, June 26, 2024 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock, rights, warrants, and units...

Loading... Loading... Shares of Teradyne, Inc. TER rose sharply in today's pre-market trading after the company posted upbeat first-quarter results and issued ...

Press release Biophytis Announces Transfer of ADSs to OTC Market ADSs delisted from Nasdaq, which will result in meaningful...

Biophytis announces delisting of its American Depositary Shares (ADSs) from Nasdaq due to non-compliance with stockholders' equity requirements.

Shares of Medical Properties Trust, Inc. (NYSE: MPW) rose sharply in today’s pre-market trading after the company announced that it sold its majority interest in Utah Hospitals.

U.S. stocks traded lower midway through trading, with the Dow Jones index falling around 150 points on Tuesday. The Dow traded down 0.39% to 38,742.12 while the NASDAQ fell 0.16% to 16,227.77. The S&P 500 also fell, dropping, 0.29% to 5,187.10.

Biophytis (BPTS) rises in the after-market hours as it announces the launch of a new clinical development program for its investigational candidate, BIO101, to treat obesity in combination with GLP-1 drugs.

Shares of Biophytis S.A. (NASDAQ: BPTS) rose sharply in today’s pre-market trading after reporting FY23 results.

Shares of Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX) rose sharply in today’s pre-market trading following fourth-quarter results.

Biophytis / Key word(s): Miscellaneous Biophytis presented its phase 3 protocol in the treatment of sarcopenia 22-March-2024...

Shares of FactSet Research Systems Inc. (NYSE: FDS) fell sharply during Thursday’s session after the company reported worse-than-expected second-quarter revenue and issued FY24 guidance.

Shares of Micron Technology, Inc. (NASDAQ: MU) rose sharply in today’s pre-market trading as the company reported upbeat results for its second quarter and issued

Biophytis announces its participation in several conferences in Europe and the US during the first quarter of 2024 Paris and Cambridge , December 11, 2023 - 07am CET -...

U.S. stocks traded mixed this morning, with the Dow Jones index gaining around 50 points on Friday. Following the market opening Friday, the Dow traded up 0.14% to 35,323.77 while the NASDAQ fell 0.13% to 14,247.68. The S&P 500 also fell, dropping, 0.02% to 4,555.53.

Gainers

Biophytis / Key word(s): Miscellaneous/Miscellaneous Biophytis receives notice of delisting from Nasdaq and announces it wil...

French public limited company with a Board of Directors with share capital of €4,267,706.99 Registered office: 14 Avenue de l'Opéra - 75001 PARIS Paris Commercial Register ...